Dr. Umit Tapan, MD
Claim this profileBoston Medical Center
Area of expertise
Lung Cancer
Umit Tapan, MD has run 8 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Umit Tapan, MD has run 6 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
Boston Medical Center
Boston Medical Center - Dept. Hematology/Oncology
Clinical Trials Umit Tapan, MD is currently running
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting
1 award
Phase 3
14 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
More about Umit Tapan, MD
Clinical Trial Related
5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Umit Tapan, MD has experience with
- Pembrolizumab
- Carboplatin
- Paclitaxel
- Pemetrexed
- InVision
- Durvalumab
Breakdown of trials Umit Tapan, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Squamous Cell Carcinoma
Lung Carcinoma
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Umit Tapan, MD specialize in?
Umit Tapan, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Umit Tapan, MD currently recruiting for clinical trials?
Yes, Umit Tapan, MD is currently recruiting for 3 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Umit Tapan, MD has studied deeply?
Yes, Umit Tapan, MD has studied treatments such as Pembrolizumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Umit Tapan, MD?
Apply for one of the trials that Umit Tapan, MD is conducting.
What is the office address of Umit Tapan, MD?
The office of Umit Tapan, MD is located at: Boston Medical Center, Boston, Massachusetts 02118 United States. This is the address for their practice at the Boston Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.